Our Keynote Session, curated and chaired by PRI Board Member Tomas de Wouters (CEO & Co-founder of PharmaBiome), is titled ‘From Concept to Consortia‘ – academic and industry representatives developing the next generation of microbiome-based medicinal products, based on the rational design of microbial consortia.
And if you want to learn about the most relevant Regulatory update which has faced the Microbiome field in several years – we have organized a full session and panel discussion on the proposal to revise the Substance of Human Origin (SoHO) regulation (read more here). Representatives from the European Commission and the European Directorate for the Quality of Medicines (EDQM) (read more about that here) have agreed to share key insights into this draft regulation (still being discussed in the European Parliament).
About the Pharmabiotics Conference & Partnering Event (21-22 March 2023 – Lyon)
Pharmabiotics Conference & Partnering is an annual scientific and industry event bringing together some of the most cutting-edge microbiome science researchers with leading biotechnology companies driving the microbiome-based medicinal product field forward.
Two full-days of leading researchers, microbiome product developers and cutting edge biotechs and startups will be on the agenda.
Go to the dedicated Conference website to get the latest information – make sure to download the final agenda using the link below: